Cargando…

Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis

Although endovascular stenting has been used as an interventional therapy to treat cardio- and cerebro-vascular diseases, it is associated with recurrent vascular diseases following stent thrombosis and in-stent restenosis. In this study, a metallic stent was coated with dopamine-conjugated hyaluron...

Descripción completa

Detalles Bibliográficos
Autores principales: Lih, Eugene, Choi, Seul Gi, Ahn, Dong June, Joung, Yoon Ki, Han, Dong Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308429/
https://www.ncbi.nlm.nih.gov/pubmed/28228930
http://dx.doi.org/10.1177/2041731416683745
_version_ 1782507529350152192
author Lih, Eugene
Choi, Seul Gi
Ahn, Dong June
Joung, Yoon Ki
Han, Dong Keun
author_facet Lih, Eugene
Choi, Seul Gi
Ahn, Dong June
Joung, Yoon Ki
Han, Dong Keun
author_sort Lih, Eugene
collection PubMed
description Although endovascular stenting has been used as an interventional therapy to treat cardio- and cerebro-vascular diseases, it is associated with recurrent vascular diseases following stent thrombosis and in-stent restenosis. In this study, a metallic stent was coated with dopamine-conjugated hyaluronic acid with different ratios of catechol group to improve hemocompatibility and re-endothelialization. Especially, we were interested in how much amount of catechol group is appropriate for the above-mentioned purposes. Therefore, a series of dopamine-conjugated hyaluronic acid conjugates with different ratios of catechol group were synthesized via a carbodiimide coupling reaction. Dopamine-conjugated hyaluronic acid conjugates were characterized with (1)H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and the amount of catechol group in dopamine-conjugated hyaluronic acid was measured by ultraviolet spectrometer. Co-Cr substrates were polished and coated with various dopamine-conjugated hyaluronic acid conjugates under pH 8.5. Dopamine-conjugated hyaluronic acid amounts on the substrate were quantified by micro-bicinchoninic acid assay. Surface characteristics of dopamine-conjugated hyaluronic-acid-coated Co-Cr were evaluated by water contact angle, scanning electron microscopy, and atomic force microscopy. The hemocompatibility of the surface-modified substrates was assessed by protein adsorption and platelet adhesion tests. Adhesion and activation of platelets were confirmed with scanning electron microscopy and lactate dehydrogenase assay. Human umbilical vein endothelial cells were cultured on the substrates, and the viability, adhesion, and proliferation were investigated through cell counting kit-8 assay and fluorescent images. Obtained results demonstrated that optimal amounts of catechol group (100 µmol) in the dopamine-conjugated hyaluronic acid existed in terms of various properties such as hemocompatibility and cellular responses.
format Online
Article
Text
id pubmed-5308429
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-53084292017-02-22 Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis Lih, Eugene Choi, Seul Gi Ahn, Dong June Joung, Yoon Ki Han, Dong Keun J Tissue Eng Original Article Although endovascular stenting has been used as an interventional therapy to treat cardio- and cerebro-vascular diseases, it is associated with recurrent vascular diseases following stent thrombosis and in-stent restenosis. In this study, a metallic stent was coated with dopamine-conjugated hyaluronic acid with different ratios of catechol group to improve hemocompatibility and re-endothelialization. Especially, we were interested in how much amount of catechol group is appropriate for the above-mentioned purposes. Therefore, a series of dopamine-conjugated hyaluronic acid conjugates with different ratios of catechol group were synthesized via a carbodiimide coupling reaction. Dopamine-conjugated hyaluronic acid conjugates were characterized with (1)H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and the amount of catechol group in dopamine-conjugated hyaluronic acid was measured by ultraviolet spectrometer. Co-Cr substrates were polished and coated with various dopamine-conjugated hyaluronic acid conjugates under pH 8.5. Dopamine-conjugated hyaluronic acid amounts on the substrate were quantified by micro-bicinchoninic acid assay. Surface characteristics of dopamine-conjugated hyaluronic-acid-coated Co-Cr were evaluated by water contact angle, scanning electron microscopy, and atomic force microscopy. The hemocompatibility of the surface-modified substrates was assessed by protein adsorption and platelet adhesion tests. Adhesion and activation of platelets were confirmed with scanning electron microscopy and lactate dehydrogenase assay. Human umbilical vein endothelial cells were cultured on the substrates, and the viability, adhesion, and proliferation were investigated through cell counting kit-8 assay and fluorescent images. Obtained results demonstrated that optimal amounts of catechol group (100 µmol) in the dopamine-conjugated hyaluronic acid existed in terms of various properties such as hemocompatibility and cellular responses. SAGE Publications 2016-12-17 /pmc/articles/PMC5308429/ /pubmed/28228930 http://dx.doi.org/10.1177/2041731416683745 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Lih, Eugene
Choi, Seul Gi
Ahn, Dong June
Joung, Yoon Ki
Han, Dong Keun
Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis
title Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis
title_full Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis
title_fullStr Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis
title_full_unstemmed Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis
title_short Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis
title_sort optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308429/
https://www.ncbi.nlm.nih.gov/pubmed/28228930
http://dx.doi.org/10.1177/2041731416683745
work_keys_str_mv AT liheugene optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis
AT choiseulgi optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis
AT ahndongjune optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis
AT joungyoonki optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis
AT handongkeun optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis